Relay Therapeutics (RLAY) Price Target Raised to $29 by H.C. Wainwright
Published on Β· Source: investing.com
AI Summary
Summarized by AI from the source belowH.C. Wainwright has raised its price target for Relay Therapeutics (RLAY) to $29. This figure marks an increase from a previously lower estimate, reflecting the firm's confidence in Relay's potential growth. The updated target suggests positive sentiment surrounding the company's future performance, which could influence investor perception and trading behavior. Investors should consider how this price target adjustment might affect market valuations for Relay Therapeutics.
Informational only, not financial advice. Content is AI-generated and may contain errors. How this works.
Get the weekly market brief
One email every Monday: what moved, why, and what to watch. Free, unsubscribe anytime.
Get stories like this as they break
Our Telegram channel posts every market story the moment it is published. Free, and you can mute or leave anytime.
